Provider records sourced from NPPES (CMS National Plan & Provider Enumeration System). Data current as of August 10, 2026.
NPIDirectory

Dr. Khulkar Mirzozoda, MD, MBA

Individual provider Interventional Cardiology Physician · NPI 1487144309

Dr. Khulkar Mirzozoda, MD, MBA is an Interventional Cardiology Physician in Philadelphia, Pennsylvania. Works from 2 locations. Licensed in Pennsylvania.

Licensed in
PA
In the registry since
2018
What do these letters mean?
MD — Doctor of Medicine
A physician who completed allopathic medical school.
MBA — Master of Business Administration
A graduate business degree.

See every abbreviation used in this directory →

Claim this listing Report a problem Suggest an edit

Practice location Address checks out

833 Chestnut St Ste 220
Philadelphia, PA 19107
Phone: (215) 955-8465
Fax: (215) 955-2516
Show map & directions

Directions in Google Maps · Apple Maps · OpenStreetMap

Pin is approximate — placed at the ZIP-code centre, not the exact door.

Additional practice locations (1)

  • 44 S Washington Ave, Greensburg, PA 15601-2768 — (724) 836-1862

Specialties & licences

Interventional Cardiology Physician (primary) Taxonomy 207RI0011X · Licence MD474832 (PA)

Record details

NPI number1487144309
Entity typeIndividual (Type 1)
GenderFemale
Credentials MD , MBA
Sole proprietorNo
NPI enumeratedMay 16, 2018
Last updated in NPPESAugust 4, 2026
Certification dateAugust 4, 2026

Medicare patients and services, 2024

From the CMS Medicare Physician & Other Practitioners file for calendar year 2024. It counts Original Medicare patients only, so a practice that mostly sees Medicare Advantage or privately insured patients looks smaller here than it is.

Medicare patients17
Services billed 18 a service is one billed item, such as a visit, a test or a procedure
Average patient age73

Dollar amounts are not shown. What Medicare pays a practice is gross billings, before staff, premises and tax and including the cost of any drugs it administers, so it is not what a clinician earns.

Payments from drug and device companies, 2025

Drug and device makers are required by federal law (the Physician Payments Sunshine Act) to report what they pay or give to clinicians, and CMS publishes the reports as Open Payments. This is the 2025 program year. A report is a record of a payment, not an allegation of anything, and many are small items such as meals. Only general payments are listed here; research payments and ownership or investment interests are reported separately by CMS and are not shown.

Grant $2,000 1 payment · funding for a project or programme, not a fee for the clinician’s time
Food and Beverage $1,093 20 payments · a meal or drink at a meeting or visit, not a fee
Travel and Lodging $510 2 payments · travel or lodging paid or reimbursed, such as to attend a conference
Education $183 1 payment · educational material or training, not a fee

Each amount is the sum of what companies reported for that kind of payment in 2025, rounded to the dollar. Not all of it is income to the clinician: a meal is not a fee, a charitable contribution goes to a charity, and a royalty or an acquisition payment is not a salary.

Check a report, or dispute one, at the source in CMS’s own tool, Open Payments. Corrections go through CMS’s dispute process. This site removes a home address on request and asks for no proof, because that is privacy; it will not remove an accurate payment report on request, because that is a statutory public disclosure.

Other providers in Philadelphia